(Q48359111)

11 February 2018

title

Ceruletide inhibits phencyclidine-induced dopamine and serotonin release in rat prefrontal cortex (English)

1 reference

11 February 2018

0 references

Etou K

1

1 reference

11 February 2018

Kuroki T

2

1 reference

11 February 2018

Kawahara T

3

1 reference

11 February 2018

Yonezawa Y

4

1 reference

11 February 2018

Tashiro N

5

1 reference

11 February 2018

Uchimura H

6

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 December 1998

1 reference

11 February 2018

Pharmacology, Biochemistry and Behavior

published in

1 reference

11 February 2018

volume

61

1 reference

11 February 2018

issue

4

1 reference

11 February 2018

page(s)

427-434

1 reference

11 February 2018

Inhibition of potassium-evoked release of cholecystokinin from rat caudate-putamen, cerebral cortex and hippocampus incubated in vitro by phencyclidine and related compounds.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokinin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Pharmacology of a cholecystokinin receptor on 5-hydroxytryptamine neurones in the dorsal raphe of the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Cholecystokinin-dopamine interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Dopamine in schizophrenia: a review and reconceptualization

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Reduction in cholecystokinin-like immunoreactivity in the basal ganglia in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Effect of local cholecystokinin-8 administration on extracellular levels of amino acids and glycolytic products monitored by in vivo microdialysis in the fronto-parietal cortex of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Effects of systemically administered ceruletide on the in vivo release and metabolism of dopamine in the medial prefrontal cortex of awake, freely moving rats: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Ceruletide suppresses endogenous dopamine release via vagal afferent system, studied by in vivo intracerebral dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Effects of administration of cholecystokinin into the VTA on DA overflow in nucleus accumbens and amygdala of freely moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Phencyclidine (PCP) injected in the nucleus accumbens increases extracellular dopamine and serotonin as measured by microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Neurotransmitter regulation of dopamine neurons in the ventral tegmental area

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Receptor selectivity of cholecystokinin effects on mesoaccumbens dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Ceruletide, a cholecystokinin-related peptide, attenuates haloperidol-induced increase in dopamine release from the rat striatum: an in vivo microdialysis study.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Differential effects of ceruletide on amphetamine-induced behaviors and regional dopamine release in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Antagonism of ceruletide, a cholecystokinin analog, to the neurochemical effects of the non-competitive N-methyl-D-aspartate (NMDA) receptor antagonists, phencyclidine and MK-801, on regional dopaminergic neurons in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

THE SYNTHESIS OF PHENCYCLIDINE AND OTHER 1-ARYLCYCLOHEXYLAMINES.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Differential Interaction of Phencyclidine-Like Drugs with the Dopamine Uptake Complex In Vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Two brain cholecystokinin receptors: implications for behavioral actions

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Antipsychotic effects of ceruletide (caerulein) on chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Cholecystokinin release mediated by 5-HT3 receptors in rat cerebral cortex and nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Cholecystokinin-8 increases K(+)-evoked [3H] gamma-aminobutyric acid release in slices from various brain areas

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

The stimulation of cholecystokinin receptors in the rostral nucleus accumbens significantly antagonizes the EEG and behavioural effects induced by phencyclidine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Cholecystokinin and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Effects of BOC-CCK-4 and L 365.260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus maze

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Regulation of the prefrontal cortical dopamine release by GABAA and GABAB receptor agonists and antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Facilitation of GABA release by cholecystokinin and caerulein in rat cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Peptide-monoamine coexistence: Studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Cholecystokinin messenger RNA deficit in frontal and temporal cerebral cortex in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Cholecystokinin antagonists inhibit in vivo voltammetric signals generated by KCl-induced slow wave depolarization in rat caudate

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Cholecystokinin antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

The effects of intraperitoneally administered phencyclidine on the central nervous system: behavioral and neurochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Effect of phencyclidine on endogenous excitatory amino acid release from the rat anterior cingulate cortex--an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Potentiation of phencyclidine-induced dopamine release in the rat striatum by the blockade of dopamine D2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2898%2900128-2

7 January 2021

10.1016/S0091-3057(98)00128-2

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018